2017
DOI: 10.1016/j.transci.2017.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of stability of CD34+ cell products enriched by immunoselection from peripheral blood mononuclear cells during refrigerated storage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…Anti-CD34 Haematopoietic stem cells [14,17,18,23,24,33,34,37,39,43,45,47,48,[54][55][56] Anti-CD3 T cells [38,40,45,47,48,50,52] Anti-CD19 Anti-CD20…”
Section: Cell Line Referencesmentioning
confidence: 99%
See 1 more Smart Citation
“…Anti-CD34 Haematopoietic stem cells [14,17,18,23,24,33,34,37,39,43,45,47,48,[54][55][56] Anti-CD3 T cells [38,40,45,47,48,50,52] Anti-CD19 Anti-CD20…”
Section: Cell Line Referencesmentioning
confidence: 99%
“…Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4 C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT. 55 Krasna et al 56 evaluated the stability of the HSC products after immunoselection and reported that CD34+ cells after selection were less stable than CD34+ cells in leukapheresis product during refrigerated storage up to 6 days. Since the results of the studies conducted so far have varied depending on the type of cellular therapy products and storage conditions, each laboratory should perform a sample stability study as part of the validation protocol.…”
Section: Stability Of the Cellular Therapy Product Samplesmentioning
confidence: 99%